Icu Medical Inc
ICUI
Surgical & Medical Instruments & Apparatus
Mkt Cap
$2.54BPE
-42.83Debt
$1.686BCash
$251.4MEV
$3.975BFCF
$85.14MP/E Ratio
-42.83Debt
$1.686BCash
$251.4MEV
$3.975BFCF
$85.14MCharts data: {"Earnings":[{"time":"2014-12-30","value":26335000},{"time":"2015-12-30","value":44985000},{"time":"2016-12-30","value":63084000},{"time":"2017-12-30","value":68644000},{"time":"2018-12-30","value":28793000},{"time":"2019-12-30","value":101035000},{"time":"2020-12-30","value":86870000},{"time":"2021-12-30","value":103135000},{"time":"2022-12-30","value":-74286000},{"time":"2023-12-30","value":-29655000}],"Sales":[{"time":"2014-12-30","value":309260000},{"time":"2015-12-30","value":341668000},{"time":"2016-12-30","value":379372000},{"time":"2017-12-30","value":1292613000},{"time":"2018-12-30","value":1400040000},{"time":"2019-12-30","value":1266208000},{"time":"2020-12-30","value":1271004000},{"time":"2021-12-30","value":1316308000},{"time":"2022-12-30","value":2279997000},{"time":"2023-12-30","value":2259126000}],"Net Margins":[{"time":"2014-12-30","value":0.08515488585656082},{"time":"2015-12-30","value":0.1316629008277041},{"time":"2016-12-30","value":0.16628533471104878},{"time":"2017-12-30","value":0.05310483493512753},{"time":"2018-12-30","value":0.020565840975972114},{"time":"2019-12-30","value":0.0797933672824686},{"time":"2020-12-30","value":0.06834754257264336},{"time":"2021-12-30","value":0.0783517231529399},{"time":"2022-12-30","value":-0.03258162181792344},{"time":"2023-12-30","value":-0.01312675787007896}],"Assets":[{"time":"2014-12-30","value":541102000},{"time":"2015-12-30","value":626825000},{"time":"2016-12-30","value":704688000},{"time":"2017-12-30","value":1496951000},{"time":"2018-12-30","value":1585391000},{"time":"2019-12-30","value":1692382000},{"time":"2020-12-30","value":1763691000},{"time":"2021-12-30","value":1880738000},{"time":"2022-12-30","value":4515641000},{"time":"2023-12-30","value":4378439000}],"Stockholders Equity":[{"time":"2014-12-30","value":508252000},{"time":"2015-12-30","value":579871000},{"time":"2016-12-30","value":660155000},{"time":"2017-12-30","value":1198254000},{"time":"2018-12-30","value":1263655000},{"time":"2019-12-30","value":1377244000},{"time":"2020-12-30","value":1502265000},{"time":"2021-12-30","value":1616031000},{"time":"2022-12-30","value":2089928000},{"time":"2023-12-30","value":2123410000}],"ROE":[{"time":"2014-12-30","value":0.05181484775268961},{"time":"2015-12-30","value":0.07757759915567428},{"time":"2016-12-30","value":0.09555937620710288},{"time":"2017-12-30","value":0.057286685460678624},{"time":"2018-12-30","value":0.022785491293114024},{"time":"2019-12-30","value":0.07336027602951982},{"time":"2020-12-30","value":0.05782601604909919},{"time":"2021-12-30","value":0.06381993909770295},{"time":"2022-12-30","value":-0.03554476517851333},{"time":"2023-12-30","value":-0.013965743780051897}],"ROA":[{"time":"2014-12-30","value":0.07214351453145618},{"time":"2015-12-30","value":0.11125593267658437},{"time":"2016-12-30","value":0.12102093408714211},{"time":"2017-12-30","value":0.03562574860499776},{"time":"2018-12-30","value":0.014559815212777164},{"time":"2019-12-30","value":0.06810282784855902},{"time":"2020-12-30","value":0.05627232888300728},{"time":"2021-12-30","value":0.0659549602336955},{"time":"2022-12-30","value":-0.008720135192323748},{"time":"2023-12-30","value":0.012694706949211808}]}
ICU Medical, Inc., together with its subsidiaries, develops, manufactures, and sells medical devices used in infusion therapy, vascular access, and vital care applications worldwide. Its infusion therapy products include needlefree products under the MicroClave, MicroClave Clear, and NanoClave brands; Neutron catheter patency devices; ChemoClave and ChemoLock closed system transfer devices, which are used to limit the escape of hazardous drugs or vapor concentrations, block the transfer of environmental contaminants into the system, and eliminates the risk of needlestick injury; and ClearGuard HD, that maintains hemodialysis catheters. The company provides IV therapy and diluents, such as sodium chloride, dextrose, balanced electrolyte solutions, lactated ringer's, ringer's, mannitol, sodium chloride/dextrose, and sterile water; and irrigation solutions comprising sodium chloride and sterile water irrigation, physiologic solutions, ringer's irrigation, acetic acid irrigation, glycine irrigation, sorbitol-mannitol irrigation, flexible containers, and pour bottle options. It offers infusion pumps under the Plum 360 brand; IV mediation safety software, including ICU Medical MedNet, an enterprise-class medication management platform that connects smart pumps to hospital's electronic health records, asset tracking systems, and alarm notification platforms; professional services; critical care products, such as Cogent 2-in-1 and CardioFlo hemodynamic monitoring systems; TDQ and OptiQ cardiac output monitoring catheters; TriOx venous oximetry catheters; Transpac blood pressure transducers; and SafeSet closed blood sampling and conservation systems. The company's customers include acute care hospitals, wholesalers, ambulatory clinics, and alternate site facilities, including outpatient clinics, home health care providers, and long-term care facilities. ICU Medical, Inc. was founded in 1984 and is headquartered in San Clemente, California.
Sector
![GKOS Logo](data:image/svg+xml,<svg xmlns='http://www.w3.org/2000/svg' width='18' height='18'><defs><linearGradient id="a" x1="3.349" x2="21.904" y1="3.122" y2="24.434" gradientUnits="userSpaceOnUse"><stop stop-color="%231A1E21"/><stop offset="1" stop-color="%2306060A"/></linearGradient></defs><path fill="url(%23a)" d="M0 0h18v18H0z"/><text x='50%' y='52%' dominant-baseline='middle' text-anchor='middle' font-size='5' font-family='sans-serif' fill='gray'>GKOS</text></svg>){kind=small}
![GMED Logo](data:image/svg+xml,<svg xmlns='http://www.w3.org/2000/svg' width='18' height='18'><defs><linearGradient id="a" x1="3.349" x2="21.904" y1="3.122" y2="24.434" gradientUnits="userSpaceOnUse"><stop stop-color="%231A1E21"/><stop offset="1" stop-color="%2306060A"/></linearGradient></defs><path fill="url(%23a)" d="M0 0h18v18H0z"/><text x='50%' y='52%' dominant-baseline='middle' text-anchor='middle' font-size='5' font-family='sans-serif' fill='gray'>GMED</text></svg>){kind=small}
DCF
Discounted Cash Flow Valuation of Icu Medical Inc
Value
Growth
%
%
Discount
%
%
Multiple
| g\r | +10% | +11% | +12% | +13% | +14% |
|---|---|---|---|---|---|
| 0% | 10 | 9 | 8 | 8 | 7 |
| +1% | 11 | 10 | 9 | 8 | 8 |
| +2% | 13 | 11 | 10 | 9 | 8 |
| +3% | 14 | 13 | 11 | 10 | 9 |
| +4% | 17 | 14 | 12 | 11 | 10 |
| Years | 0 | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | TV |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| FCF | $85.14M | $92.18M | $99.46M | $107M | $114.6M | $122.4M | $130.3M | $138.3M | $146.2M | $154M | $161.7M | $1.617B |
| DCF | $80.16M | $75.21M | $70.33M | $65.54M | $60.88M | $56.35M | $51.99M | $47.79M | $43.79M | $39.98M | $399.8M | |
| Value | $991.8M | |||||||||||
In the chart Earnings are multiplied by this value.
Earnings Growth 2.8%
Earnings Stability -19%
Competitiveness and MOAT
High margins render the company resilient under dire circumstances, hence able to drive competitors out or acquire them. ROE and ROA measure the average flow generated by each invested dollar. Their marginal value is a forecast of future growth, and it is considered by Buffett and Munger the most important single indicator.
| Years | 12-2015 | 12-2016 | 12-2017 | 12-2018 | 12-2019 | 12-2020 | 12-2021 | 12-2022 | 12-2023 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|
| Net Margin | 13% | 17% | 5.3% | 2.1% | 8% | 6.8% | 7.8% | -3.3% | -1.3% | -2.6% |
| ROA | 11% | 12% | 3.6% | 1.5% | 6.8% | 5.6% | 6.6% | -0.87% | 1.3% | 0.83% |
| ROE | 7.8% | 9.6% | 5.7% | 2.3% | 7.3% | 5.8% | 6.4% | -3.6% | -1.4% | -2.9% |
What is the average Net Margin?
The average Net Margin over the past 5 years is +3.36%.
What is the trend of Net Margin?
The trend of Net Margin over the past 5 years is -1.42%.
What is the average Return on Assets (ROA)?
The average ROA over the past 5 years is +3.48%.
What is the trend of Return on Assets (ROA)?
The trend of ROA over the past 5 years is -0.66%.
What is the average Return on Equity (ROE)?
The average ROE over the past 5 years is +2.8%.
What is the trend of Return on Equity (ROE)?
The trend of ROE over the past 5 years is -1.44%.
Safety & Stabiliy
Being debt the number one cause of investment losses and company death, the ratio Debt/FCF is of utmost importance to guarantee safety. On the other hand the Graham’s stability measures the drawdown of earnings, hence indicating the reliability of the flow generated by the company.
| Years | 12-2015 | 12-2016 | 12-2017 | 12-2018 | 12-2019 | 12-2020 | 12-2021 | 12-2022 | 12-2023 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|
| Debt FCF | - | 0.00 | - | - | 0.00 | - | 0.00 | -11.20 | 20.64 | 19.80 |
| Debt Equity | - | 0.00 | - | - | 0.00 | - | 0.00 | 0.82 | 0.80 | 0.82 |
| MIN | ||||||||||
| Graham Stability | - | - | 100% | 49% | 100% | 100% | 100% | -77% | -77% | -77% |
What is the Debt/FCF?
The Debt/FCF trailing twelve month is 19.80.
What is the trend of Debt/FCF?
The trend of Debt/FCF over the past 5 years is 3.17.
What is the Graham’s Stability?
Graham’s Stability measure stands at -0.77.
Growth
Growth can be dangerous when forecasting, simply projecting the current growth is in general wrong. A company passes through multiple phases, from being young and unprofitable, to the first periods of profitability and high growth, until it arrives at a period of regime with limited growth. Identifying in which phase the company is in may help forecasting.
| Years | 12-2016 | 12-2018 | 12-2020 | 12-2022 | Trend |
|---|---|---|---|---|---|
| Revenue | 29% | 10% | 21% | -0.92% | -5.7% |
| Net Income | - | - | - | - | -0.81% |
| Stockholders Equity | 18% | 11% | 12% | 1.6% | -2.5% |
| FCF | 3.1% | 4% | -14% | - | 190% |
What is the 5 year Revenue CAGR?
The Revenue CAGR over the past 5 years is +10.04%.
What is the trend of Revenue growth?
The trend of Revenue growth rate over the past 5 years is -5.69%.
What is the 5 year Earnings CAGR?
The Earnings CAGR over the past 5 years is -.
What is the trend of Earnings growth?
The trend of Earnings growth rate over the past 5 years is -0.81%.
What is the 5 year Equity CAGR?
The Equity CAGR over the past 5 years is +10.94%.
What is the trend of Equity growth?
The trend of Equity growth rate over the past 5 years is -2.46%.
What is the 5 year FCF CAGR?
The FCF CAGR over the past 5 years is +4.05%.
What is the trend of FCF growth?
The trend of FCF growth rate over the past 5 years is +193.48%.